Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 72, Issue 9
Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Editorial
Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples
Free
Online download statistics by month:
Online download statistics by month: April 2013 to March 2024
Abstract
Full
Pdf
Apr 2013
0
102
120
May 2013
0
160
120
Jun 2013
58
27
33
Jul 2013
98
32
39
Aug 2013
780
541
501
Sep 2013
747
163
163
Oct 2013
202
75
102
Nov 2013
85
57
64
Dec 2013
56
50
58
Jan 2014
62
41
55
Feb 2014
83
67
82
Mar 2014
75
46
75
Apr 2014
76
31
50
May 2014
78
30
53
Jun 2014
58
41
38
Jul 2014
57
27
21
Aug 2014
45
17
11
Sep 2014
62
29
32
Oct 2014
77
34
34
Nov 2014
61
34
42
Dec 2014
48
35
40
Jan 2015
57
21
29
Feb 2015
50
27
28
Mar 2015
75
26
28
Apr 2015
56
27
30
May 2015
53
24
29
Jun 2015
30
12
12
Jul 2015
38
16
17
Aug 2015
45
17
22
Sep 2015
71
20
38
Oct 2015
39
6
36
Nov 2015
66
14
24
Dec 2015
62
19
16
Jan 2016
68
18
32
Feb 2016
58
17
35
Mar 2016
38
22
42
Apr 2016
57
9
37
May 2016
50
15
33
Jun 2016
22
6
30
Jul 2016
33
17
34
Aug 2016
44
13
38
Sep 2016
38
19
42
Oct 2016
66
19
47
Nov 2016
29
16
24
Dec 2016
28
16
20
Jan 2017
44
11
26
Feb 2017
5
3
15
Mar 2017
2
27
15
Apr 2017
0
35
23
May 2017
1
52
39
Jun 2017
5
15
11
Jul 2017
27
24
23
Aug 2017
43
41
36
Sep 2017
34
36
18
Oct 2017
38
30
14
Nov 2017
23
21
15
Dec 2017
27
23
8
Jan 2018
25
25
8
Feb 2018
27
26
12
Mar 2018
49
48
6
Apr 2018
90
88
13
May 2018
62
62
12
Jun 2018
62
62
8
Jul 2018
39
37
2
Aug 2018
47
47
14
Sep 2018
74
74
5
Oct 2018
90
90
9
Nov 2018
190
142
14
Dec 2018
83
83
1
Jan 2019
62
59
5
Feb 2019
53
54
4
Mar 2019
32
30
12
Apr 2019
17
17
11
May 2019
21
21
8
Jun 2019
17
17
4
Jul 2019
14
14
13
Aug 2019
17
17
4
Sep 2019
14
14
5
Oct 2019
16
16
11
Nov 2019
9
7
7
Dec 2019
18
16
3
Jan 2020
19
15
8
Feb 2020
16
10
4
Mar 2020
14
12
7
Apr 2020
13
11
4
May 2020
12
12
4
Jun 2020
9
9
3
Jul 2020
12
12
5
Aug 2020
18
13
4
Sep 2020
26
20
4
Oct 2020
19
15
10
Nov 2020
24
13
8
Dec 2020
28
16
6
Jan 2021
11
11
1
Feb 2021
25
25
12
Mar 2021
17
17
9
Apr 2021
13
13
3
May 2021
16
16
4
Jun 2021
22
22
6
Jul 2021
16
16
9
Aug 2021
12
12
10
Sep 2021
20
19
3
Oct 2021
13
13
23
Nov 2021
7
7
17
Dec 2021
12
12
2
Jan 2022
47
50
8
Feb 2022
10
10
4
Mar 2022
15
13
6
Apr 2022
16
16
2
May 2022
36
34
15
Jun 2022
23
23
7
Jul 2022
26
25
2
Aug 2022
22
20
11
Sep 2022
24
24
9
Oct 2022
23
22
5
Nov 2022
12
11
6
Dec 2022
15
11
5
Jan 2023
9
9
5
Feb 2023
36
35
2
Mar 2023
2
2
3
Apr 2023
5
5
9
May 2023
10
4
5
Jun 2023
10
10
6
Jul 2023
12
10
9
Aug 2023
3
3
23
Sep 2023
8
8
17
Oct 2023
21
17
3
Nov 2023
19
17
4
Dec 2023
17
15
3
Jan 2024
3
3
1
Feb 2024
10
7
2
Mar 2024
16
16
45
Total
6202
4200
3273
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF